[No authors listed]
Ovarian cancer (OC) is the gynecological malignancy type with the highest mortality rate in females. The regulatory effect of microRNAs (miRs) on their target genes serves a key role in tumor development. Therefore, in the present study, whether miR letâ7dâ5p targeting high mobility group A1 (HMGA1) regulated biological characteristics and chemosensitivity of OC cells by mediating the p53 signaling pathway was investigated. The letâ7dâ5p level was detected in OC tissues and adjacent normal tissues, followed by detection in OC cell lines SKOV3, A2780, OVCARâ3 and CaOV3, and human normal ovarian epithelial cell line (IOSEâ80), in order to select the OC cell line for the following experiments. Subsequently, OC cells were treated with the letâ7dâ5p mimic, siHMGA1 and Tenovinâ1. The targeting association between letâ7dâ5p and HMGA1 was then examined, and the OC cell viability, migration, cycle and apoptosis were evaluated. Subsequently, the chemosensitivity of OC cells to cisplatin was verified. Finally, expression levels of letâ7dâ5p, HMGA1, p21, Bâcell lymphomaâ2 (Bclâ2)âassociated X (Bax), p27, p53 wildâtype (p53wt), p53 mutated (p53mut), proliferating cell nuclear antigen (PCNA), cyclinâdependent kinase 2 (CDK2), matrix metallopeptidase (MMP)2, MMP9 and Bclâ2 were determined. As demonstrated in the results, letâ7dâ5p expression was low in OC tissues and had an increased reduction in the OVCARâ3 cell line. HMGA1 was confirmed as a target of letâ7dâ5p, and its expression was also silenced by letâ7dâ5p. letâ7dâ5p repressed OC cell viability, migration, cell cycle progression and apoptosis, while it promoted the chemosensitivity of OC cells to cisplatin by targeting HMGA1. The expression of letâ7dâ5p, p21, Bax, p27 and p53wt was increased, while that of HMGA1, p53mut, PCNA, CDK2, MMP2, MMP9 and Bclâ2 was reduced following cell transfection. The results in the present study provided evidence that letâ7dâ5p may suppress proliferation, and facilitate apoptosis and cisplatin chemosensitivity of OC cells by silencing HMGA1 via the p53 signaling pathway.
KEYWORDS: {{ getKeywords(articleDetailText.words) }}
Sample name | Organism | Experiment title | Sample type | Library instrument | Attributes | |||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
{{attr}} | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
{{ dataList.sampleTitle }} | {{ dataList.organism }} | {{ dataList.expermentTitle }} | {{ dataList.sampleType }} | {{ dataList.libraryInstrument }} | {{ showAttributeName(index,attr,dataList.attributes) }} |
{{ list.authorName }} {{ list.authorName }} |